 
				Cloxotestosterone acetate
Подписчиков: 0, рейтинг: 0
			|  | |
|  | |
| Clinical data | |
|---|---|
| Trade names | Caprosem | 
| Other names | Testosterone 17β-chloral hemiacetal O-acetate; 17β-(1-(Acetyloxy)-2,2,2-trichloroethoxy)androst-4-en-3-one | 
| Routes of administration | Intramuscular injection | 
| Identifiers | |
| 
 | |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| Chemical and physical data | |
| Formula | C23H31Cl3O4 | 
| Molar mass | 477.85 g·mol−1 | 
| 3D model (JSmol) | |
| 
 | |
| 
 | |
Cloxotestosterone acetate (INN; brand name Caprosem), also known as testosterone 17β-chloral hemiacetal O-acetate, is a synthetic, injected anabolic–androgenic steroid (AAS) and an androgen ether and ester – specifically, the O-acetate ester of cloxotestosterone, the 17β-trichloro hemiacetal ether of testosterone. It is administered via intramuscular injection as a 100 mg, 2 mL aqueous suspension and lasts 4 to 6 weeks with a single administration. The drug was first marketed in the early 1960s.
See also
| AR | 
 | ||||||
|---|---|---|---|---|---|---|---|
| GPRC6A | 
 | ||||||